中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

吲哚菁绿清除试验对HBV相关慢加急性肝衰竭患者短期预后的评估

都泓莲 何鸿雁 肖慈君 王波 李烨 盛云建 邓存良

引用本文:
Citation:

吲哚菁绿清除试验对HBV相关慢加急性肝衰竭患者短期预后的评估

DOI: 10.3969/j.issn.1001-5256.2019.12.024
基金项目: 

西南医科大学校级青年基金(2017-ZRQN-022); 

详细信息
  • 中图分类号: R575.3;R512.62

Value of indocyanine green clearance test in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure

Research funding: 

 

  • 摘要:

    目的探索吲哚菁绿(ICG)清除试验对HBV相关性慢加急性肝衰竭(ACLF)患者短期预后的价值,使用吲哚菁绿15分钟滞留率(ICGR15)联合MELD评分及CTP评分建立新的预后评估模型,为构建HBV-ACLF短期预后的理想模型提供依据。方法收集2017年6月-2019年1月西南医科大学附属医院感染科收治的97例HBV-ACLF患者的临床资料,按基础肝病分为慢性乙型肝炎(CHB)组和肝硬化组,根据随访3个月时的转归分为死亡组和存活组,检测患者确诊时的ICGR15及生化、凝血等指标,同时计算CTP、MELD评分。符合正态分布的计量资料组间比较采用t检验;非正态分布计量资料组间比较采用Mann-Whitney U检验。计数资料组间比较采用χ2检验,ICGR15与各变量之间的相关性分析采用Spearman等级相关检验。应用二分类logistic回归分析的方法,建立HBV-ACLF的联合预测模型MELD-ICGR15、CTP-ICGR15。应用受试者工作特征(ROC...

     

  • [1] MA CH,CHEN Y,CHEN CW,et al. Prognostic value of indocyanine green and liver reserve function in acute and acuteon-chronic liver failure patients[J]. J Clin Hepatol,2012,28(5):372-375.(in Chinese)马春华,陈煜,陈成伟,等.吲哚菁绿清除试验对急性/慢加急性肝衰竭患者预后的评价[J].临床肝胆病杂志,2012,28(5):372-375.
    [2] WU KL,ZHANG Y,HUANG J,et al. Model for end-stage liver disease combined with indocyanine green clearance test can effectively predict the prognosis of HBV-Associated acute-on-chronic liver failure[J]. J Sun Yat-Sen Univ(Medical Sciences),2018,39(6):935-940.(in Chinese)吴坤亮,张英,黄晶,等.终末期肝病模型评分联合吲哚菁绿清除实验预测HBV相关慢加急性肝衰竭预后[J].中山大学学报(医学科学版),2018,39(6):935-940.
    [3] Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese,Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.
    [4] Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,CMA; Severe Liver Disease and Artificial Liver Group,Chinese Society of Hepatology,CMA. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol,2019,35(1):38-44.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].临床肝胆病杂志,2019,35(1):38-44.
    [5] MURRAY-LYON IM,PUGH RN,NUNNERLEY HB,et al.Treatment of bleeding oesophageal varices by infusion of vasopressin into the superior mesenteric artery[J]. Gut,1973,14(1):59-63.
    [6] KAMATH PS,WIESNER RH,MALINCHOC M,et al. A model to predict survival in patients with end-stage liver disease[J]. Hepatology,2001,33(2):464-470.
    [7] SARIN SK,KUMAR A,ALMEIDA JA,et al. Acute-on-chronic liver failure:Consensus recommendations of the Asian Pacific Association for the study of the liver(APASL)[J]. Hepatol Int,2009,3(1):269-282.
    [8] LION IW,LARSON AM. Rele of liver transplantation in acute liver failure[J]. Semin Liver Dis,2008,28(2):201-209.
    [9] MOREAU R. Acute-on-chronic liver failure:A new syndrome in cirrhosis[J]. Clin Mol Hepatol,2016,22(1):1-6.
    [10] FAN HL,YANG PS,CHEN HW,et al. Predictors of the outcomes of acute-on-chronic hepatitis B liver failure[J]. World J Gastroenterol,2012,18(36):5078-5083.
    [11] ZHANG H,JIA L,YAO SW,et al. Value of MELD combined with serum sodium concentration in predicting the short-term outcome of patients with HBV-related acute-on-chronic liver failure in China:A meta-analysis[J]. J Clin Hepatol,2018,34(9):1950-1955.(in Chinese)张辉,贾雷,姚士伟,等.MELD-Na评分对我国HBV相关慢加急性肝衰竭短期预后预测价值的Meta分析[J].临床肝胆病杂志,2018,34(9):1950-1955.
    [12] DUSEJA A,CHOUDHARY NS,GUPTA S,et al. APACHE II score is superior to SOFA,CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure(ACLF)[J]. J Dig Dis,2013,14(9):484-490.
    [13] LI Q,YUAN GY,TANG KC,et al. Prognostic factors for chronic severe hepatitis and construction of a prognostic model[J].Hepatobiliary Pancreat Dis Int,2008,7(1):40-44.
    [14] WANG JX,CHENG N,XIANG TX,et al. Establishment and evaluation of short-term prognostic model for hepatitis B virus-related acute-on-chronic liver failure[J]. J Clin Hepatol,2019,35(6):1299-1303.(in Chinese)王嘉鑫,程娜,向天新,等.HBV相关慢加急性肝衰竭短期预后模型的建立及评价[J].临床肝胆病杂志,2019,35(6):1299-1303.
    [15] ZIPPRICH A,KUSS O,ROGOWSKI S,et al. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease(MELD-ICG)improves prognostic accuracy in intermediate to advanced cirrhosis[J]. Gut,2010,59(7):963-968.
  • 加载中
计量
  • 文章访问数:  1159
  • HTML全文浏览量:  16
  • PDF下载量:  250
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-08-10
  • 出版日期:  2019-12-20
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回